GIP
SRNE

Granite Investment Partners’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Granite Investment Partners’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-116,343
Closed -$626K – 310
2016
Q1 		$626K Buy
116,343
+26,721
+30% +$155K 0.06% 266
2015
Q4 		$781K Buy
89,622
+27,897
+45% +$235K 0.07% 251
2015
Q3 		$517K Buy
61,725
+17,864
+41% +$285K 0.05% 264
2015
Q2 		$772K Buy
+43,861
New +$564K 0.07% 245

Other funds holding SRNE

WCM
Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Granite Investment Partners's SRNE Position: Q2 2016 in Review

Granite Investment Partners sold out of Sorrento Therapeutics, Inc. (SRNE) in Q2 2016, closing a stake of 116,343 shares — an estimated $626K sold.

Granite Investment Partners first reported a position in SRNE in Q2 2015 and held it in 4 quarters. The position peaked at $781K in Q4 2015. 62 funds tracked by Wall St. Rank hold SRNE as of Q2 2016.

  • Granite Investment Partners reported no remaining Sorrento Therapeutics, Inc. position as of Q2 2016 after selling out during the quarter.
  • Granite Investment Partners sold 116,343 Sorrento Therapeutics, Inc. shares in Q2 2016, an estimated $626K.
  • Granite Investment Partners first reported a position in Sorrento Therapeutics, Inc. in Q2 2015 and held it in 4 quarters.
  • Granite Investment Partners's Sorrento Therapeutics, Inc. position peaked at $781K in Q4 2015.
  • 62 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q2 2016.

Based on Granite Investment Partners's 13F filing for Q2 2016, filed 15 Aug 2016.